| 000 | 01527 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513135231.0 | ||
| 264 | 0 | _c19980319 | |
| 008 | 199803s 0 0 eng d | ||
| 022 | _a0006-2952 | ||
| 024 | 7 |
_a10.1016/s0006-2952(97)00480-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aReber, U | |
| 245 | 0 | 0 |
_aPotentiation of treosulfan toxicity by the glutathione-depleting agent buthionine sulfoximine in human malignant glioma cells: the role of bcl-2. _h[electronic resource] |
| 260 |
_bBiochemical pharmacology _cFeb 1998 |
||
| 300 |
_a349-59 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xtherapeutic use |
| 650 | 0 | 4 |
_aBrain Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aBusulfan _xanalogs & derivatives |
| 650 | 0 | 4 |
_aButhionine Sulfoximine _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aGene Transfer Techniques |
| 650 | 0 | 4 |
_aGlioma _xdrug therapy |
| 650 | 0 | 4 |
_aGlutathione _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aProhibitins |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xgenetics |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aWüllner, U | |
| 700 | 1 | _aTrepel, M | |
| 700 | 1 | _aBaumgart, J | |
| 700 | 1 | _aSeyfried, J | |
| 700 | 1 | _aKlockgether, T | |
| 700 | 1 | _aDichgans, J | |
| 700 | 1 | _aWeller, M | |
| 773 | 0 |
_tBiochemical pharmacology _gvol. 55 _gno. 3 _gp. 349-59 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0006-2952(97)00480-2 _zAvailable from publisher's website |
| 999 |
_c9452996 _d9452996 |
||